> Detailanzeige

Kominers, Scott Duke [Verfasser:in] ; Pathak, Parag A. [Sonstige Person, Familie und Körperschaft]; Sönmez, Tayfun [Sonstige Person, Familie und Körperschaft]; Ünver, M. Utku [Sonstige Person, Familie und Körperschaft] National Bureau of Economic Research

Paying It Backward and Forward

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Book
  • Titel: Paying It Backward and Forward : Expanding Access to Convalescent Plasma Therapy Through Market Design
  • Beteiligte: Kominers, Scott Duke [Verfasser:in]; Pathak, Parag A. [Sonstige Person, Familie und Körperschaft]; Sönmez, Tayfun [Sonstige Person, Familie und Körperschaft]; Ünver, M. Utku [Sonstige Person, Familie und Körperschaft]
  • Körperschaft: National Bureau of Economic Research
  • Erschienen: Cambridge, Mass: National Bureau of Economic Research, 2020
  • Erschienen in: NBER working paper series ; no. w27143
  • Umfang: 1 Online-Ressource; illustrations (black and white)
  • Sprache: Englisch
  • DOI: 10.3386/w27143
  • Identifikator:
  • Reproduktionsnotiz: Hardcopy version available to institutional subscribers
  • Entstehung:
  • Anmerkungen: System requirements: Adobe [Acrobat] Reader required for PDF files
    Mode of access: World Wide Web
  • Beschreibung: COVID-19 convalescent plasma (CCP) therapy is currently a leading treatment for COVID-19. At present, there is a shortage of CCP relative to demand. We develop and analyze a model of centralized CCP allocation that incorporates both donation and distribution. In order to increase CCP supply, we introduce a mechanism that utilizes two incentive schemes, respectively based on principles of "paying it backward" and "paying it forward." Under the first scheme, CCP donors obtain treatment vouchers that can be transferred to patients of their choosing. Under the latter scheme, patients obtain priority for CCP therapy in exchange for a future pledge to donate CCP if possible. We show that in steady-state, both principles generally increase overall treatment rates for all patients--not just those who are voucher-prioritized or pledged to donate. Our results also hold under certain conditions if a fraction of CCP is reserved for patients who participate in clinical trials. Finally, we examine the implications of pooling blood types on the efficiency and equity of CCP distribution
  • Zugangsstatus: Freier Zugang